(Q43861573)

27 November 2017

Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein (English)

1 reference

27 November 2017

0 references

1 reference

7

Mathias Jucker

1 reference

27 November 2017

6

Matthias Staufenbiel

1 reference

27 November 2017

Luis F Maia

1

1 reference

27 November 2017

Stephan A Kaeser

2

1 reference

27 November 2017

Julia Reichwald

3

1 reference

27 November 2017

Michael Hruscha

4

1 reference

27 November 2017

Peter Martus

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

Science Translational Medicine

27 November 2017

1 reference

27 November 2017

5

1 reference

27 November 2017

194

1 reference

27 November 2017

194re2

1 reference

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

27 November 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Cerebrospinal fluid biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Physiological release of endogenous tau is stimulated by neuronal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Report of the task force on designing clinical trials in early (predementia) AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006446

10.1126/SCITRANSLMED.3006446

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference